Home@>@Bibliography

Bibliography

Peer-reviewed Paper

  1. Tatsuo Igarashi, Ken Marumo, Tetsuro Onishi, Mikio Kobayashi, Keisuke Aiba, Tomoyasu Tsushima, Seiichiro Ozono, Yoshihiko Tomita, Toshiro Terachi, Yoshiaki Satomi, Juichi Kawamura, and the Japanese Study Group against Renal Cancer. Interferon-alpha and 5-fluorouracil therapy in patients with metastatic renal cell cancer : An open multicenter trial. Urology, 1999; 53 : 53-59.
  2. Ken Marumo, Yoshiaki Satomi, Noriomi Miyao, Michihiko Hasegawa, Yoshihiko Tomita, Tasuo Igarashi, Tetsuro Onishi, Hayakazu Nakazawa, Momokuni Fukuda, Seiichiro Ozono, Toshiro Terachi, Tomoyasu Tsushima, Takahisa Nakamoto, Juichi Kawamura and the Japanese Society of Renal Cancer. The prevalence of renal cell carcinoma : A nation-wide survey in Japan. Int J Urol, 2001; 8:359-365.
  3. Seiichiro Ozono, Noriomi Miyao, Tatsuo Igarashi, Ken Marumo, Hayakazu Nakazawa, Momokuni Fukuda, Tomoyasu Tsushima, Noriaki Tokuda, Juichi Kawamura, Masaru Murai and Collaboration Group of Japanese Society of Renal Cancer. Tumor doubling time of renal cell carcinoma measured by CT : Collaboration of Japanese Society of Renal Cancer. Jpn J Clin Oncol, 2004; 34(2): 82-85.
  4. Tokuda N, Naito S, Matsuzaki O, Nagashima Y, Ozono S, Igarashi T, Japanese Society of Renal Cancer . Collecting Duct (Bellini Duct) Renal Cell Carcinoma: A Nationwide Survey in Japan. J Urol, 2006; 176(1): 40-43.
  5. Ken Marumo, Hiroomi Kanayama, Noriomi Miyao, Hayakazu Nakazawa,Seiichiro Ozano, Sigeo Horie, Satoshi Nagamori, Tatsuo Igarashi,Michihiko Hasegawa, Go Kimura, Masahiro Nakao, Takahisa Nakamoto,Seiji Naito, and Japanese Study Group Against Renal Cancer.@Prevalence of renal cell carcinoma: A nation-wide survey in japan,2002. Int J Urol, 2007; 14:479-482.
  6. Senga Y, Ozono S, Nakazawa H, Nagamori S, Marumo K, Horie S, Onishi T, Miyao N, Nakao M, Igarashi T, Tsushima T, Hasegawa M, Murai M; the Japanese Society of Renal Cancer (JSRC): Surgical outcomes of partial nephrectomy for renal cell carcinoma: A joint study by the Japanese Society of Renal Cancer. Int J Urol. 2007; 14(4):284-248.
  7. Keiichi Ito, Hayakazu Nakazawa, Ken Marumo, Seiichiro Ozono, Tatsuo Igarashi, Nobuo Shinohara, Momokuni Fukuda, Tomoyasu Tsushima, Seiji Naito, and Masamichi Hayakawa. Risk Factors for Ipsilateral Adrenal Involvement in Renal Cell Carcinoma. J Urol, 2008; 72(2): 354-358.
  8. Noriomi Miyao, Seiji Naito, Seiichiro Ozono, Nobuo Shinohara, Naoya Masumori, Tatsuo Igarashi, Masahiro Nakao, Tomoyasu Tsushima, Yutaka Senga, Shigeo Horie, Hiro-omi Kanayama, Noriaki Tokuda, and Mikio Kobayashi, for the Japanese Society of Renal Cancer. Late Recurrence of Renal Cell Carcinoma: Retrospective and Collaborative Study of the Japanese Society of Renal Cancer. Urology 2011; 77(2): 379-384.
  9. Masanori Hirono, Mikio Kobayashi, Tomoyasu Tsushima, Wataru Obara, Nobuo Shinohara, Keiichi Ito, Masatoshi Eto, Tatsuya Takayama, Yasuhisa Fujii, Masaharu Nishikido, Go Kimura, Takeshi Kishida, Masayuki Takahashi, Noriomi Miyao, Yukio Naya, Takashige Abe, Tomoaki Fujioka, Kazuto Ito, Seiji Naito, Members of the Japanese Society of Renal Cancer Impacts of clinicopathologic and operative factors on short-term and long-term survival in renal cell carcinoma with venous tumor thrombus extension: a multi-institutional retrospective study in Japan BMC Cancer 2013,13:447
  10. N. Shinohara, N. Nonomura2 M. Eto, G. Kimura, H. Minami, S. Tokunaga ,S. Naito A randomized multicenter phase II trial on the efficacy of a hydrocolloid dressing containing ceramide with a low-friction external surface for hand-foot skin reaction caused by sorafenib in patients with renal cell carcinoma. Annals of Oncology 2013 00: 1-5

Congress Presentations

  1. Tatsuo Igarashi, Ken Marumo, Tetsuro Onishi, Mikio Kobayashi, Keisuke Aiba, Tomoyasu Tsushima, Seiichiro Ozono, Yoshihiko Tomita, Toshiro Terachi, Yoshiaki Satomi, Juichi Kawamura, and the Japanese Study Group against Renal Cancer: Interferon-alpha plus 5-FU therapy in metastatic renal cell cancer: A multicenter trial by the Japanese Study Group against Renal Cell Cancer.

    Proceeding of 32nd Annual Meeting of American Society of Clinical Oncology (April, 1996).

  2. Tatsuo Igarashi, Ken Marumo, Tetsuro Onishi, Mikio Kobayashi, Yoshiaki Satomi, Keisuke Aiba, Juichi Kawamura: Interferon-alpha plus 5-FU therapy in metastatic renal cell cancer: A multicenter trial by the Japanese Study Group against Renal Cell Cancer.

    The 34th Annual Meeting Of Japan Society of Clinical Oncology(November, 1996).

  3. Ken Marumo, Yoshiaki Satomi, Noriomi Miyao, Takahisa Nakamoto, Makoto Yanagawa, Juichi Kawamura and the Japanese Society of Renal Cancer. The prevalence of renal cell carcinoma : A nation-wide survey in Japan.

    The 88th Annual Meeting Of Japanese Urological Association (April,2000).

  4. Seiichiro Ozono, Noriomi Miyao, Tatsuo Igarashi, Go Kimura, Shigeo Isaka, Ken Marumo, Hayakazu Nakazawa, Momokuni Fukuda, Masahiro Nakao, Tomoyasu Tsushima, Noriaki Tokuda, Juichi Kawamura, Masaru Murai and Collaboration Group of Japanese Society of Renal Cancer. :Tumor doubling time of renal cell carcinoma measured by CT : Collaboration of Japanese Society of Renal Cancer.

    The 89th Annual Meeting Of Japanese Urological Association (April,2001).

  5. Senga Y, Nakazawa H, Ozono S, Nagamori S, Marumo K, Horie S, Onishi T, Miyao N, Nakao M, Igarashi T, Tsushima T, Hasegawa M, Murai M; the Japanese Society of Renal Cancer (JSRC): Surgical outcomes of partial nephrectomy for renal cell carcinoma: A joint study by the Japanese Society of Renal Cancer.

    The 91th Annual Meeting Of Japanese Urological Association (April,2003).

  6. Noriomi Miyao, Seiji Naito, Seiichiro Ozono, Satoshi Nagamori, Nobuo Shinohara, Tatsuo Igarashi, Masahiro Nakao, Tomoyasu Tsushima, Mikio Kobayashi, Masatoshi Eto, Yutaka Senga, Shigeo Horie, Hiro-omi Kanayama:for the Japanese Society of Renal Cancer. Late Recurrence of Renal Cell Carcinoma: Retrospective and Collaborative Study of the Japanese Society of Renal Cancer.

    The 94th Annual Meeting Of Japanese Urological Association (April,2006)

  7. Noriaki Tokuda, Seiji Naito, Osamu Matsuzaki, Yoji Nagasima, Seiichiro Ozono, Masaru Murai and Japanese Society of Renal Cancer: Collecting duct (Bellini duct) renal cell carcinoma: a nation-wide survey in Japan.

    The 25th Congress of Japanese Society of Renal Cancer (April,2003).

  8. Noriaki Tokuda, Seiji Naito, Osamu Matsuzaki, Yoji Nagasima, Seiichiro Ozono, Hayakazu@Nakazawa, Masaru Murai and Japanese Society of Renal Cancer: Collecting duct (Bellini duct) renal cell carcinoma: a nation-wide survey in Japan.

    The 41th Annual Meeting Of Japan Society of Clinical Oncology(October, 2003).

  9. Noriaki Tokuda, Seiji Naito, Osamu Matsuzaki, Yoji Nagasima, Seiichiro Ozono, Hayakazu@Nakazawa, Masaru Murai and Japanese Society of Renal Cancer: Collecting duct (Bellini duct) renal cell carcinoma: a nation-wide survey in Japan.

    The 99th Annual meeting of American Urological Association iMay, 2005j,San Francisco,USA

  10. Keiichi Ito, Hayakazu Nakazawa, Ken Marumo, Seiichiro Ozono, Tatsuo Igarashi, Nobuo Shinohara, Momokuni Fukuda, Tomoyasu Tsushima, Seiji Naito, and Masamichi Hayakawa. Risk Factors for Ipsilateral Adrenal Involvement in Renal Cell Carcinoma

    The 43rd Annual Meeting Of Japan Society of Clinical Oncology(October, 2005).

  11. Keiichi Ito, Tomoyasu Asano, Mizuguchi Yasunori, Akio Horiguchi , Fumihiro Kimura, Makoto Sumitomo, Masamichi Hayakawa, Tomoyasu Tsushima, Seji Naito and Japanese Society of Renal Cancer. Preservation of ipsilateral adrenal in radical nephrectomy -A multi-center retrospective study.

    The 34th Congress of Japanese Society of Renal Cancer (October, 2007)

  12. Masanori Hirono, Kazuhiro Suzuki, Ito Kazuto, Mikio Kobayashi, Nobuo shinohara, Hiromi Kumon, Masamichi Hayakawa, Seiji Naito, Seiichiro Ozono, Iwao FukuiAHiroshi Kanetake, Yukihiro KondoFImpact of clinicopathologic and operative factors on short-term and long-term survival in renal cell carcinoma with venous tumor thrombus extension before introducing molecular-targeted therapy: multi-institutional study in Japan.

    The 47th Annual Meeting Of Japan Society of Clinical Oncology(October, 2009)

  13. Masanori Hirono, Kazuhiro Suzuki, Ito Kazuto, Mikio Kobayashi, Nobuo shinohara, Hiromi Kumon, Masamichi Hayakawa, Seiji Naito, Seiichiro Ozono, Iwao Fukui, Nishikido, Masaharu, Go Kimura, Tatsuo Igarashi: Impact of clinicopathologic and operative factors on short-term and long-term survival in renal cell carcinoma with venous tumor thrombus extension before introducing molecular-targeted therapy: multi-institutional study in Japan.

    The 98th Annual Meeting Of Japanese Urological Association (April,2010)

  14. N. Shinohara, N. Nonomura, G. Kimura, M. Eto, H. Minami, N. Yamazaki, S. Naito, Japanese Society of Renal Cancer: A randomized multi-center phase II trial on efficacy of high-slip skin care pad for hand-foot skin reaction caused by sorafenib in patients with renal cell carcinoma.

    ASCO 2011 Annual Meeting (June 2011)

Copyright (C) 2008 Japanese Society of Renal Cancer. All Rights Reserved.